Quantitative analysis of donepezil binding to acetylcholinesterase using positron emission tomography and [5-11C-methoxy]donepezil

No abstract is available for this paper.

• Publication year

  2009

• Venue

  NeuroImage

• Publication date

  2009-07-01

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1016/j.neuroimage.2009.03.006PMID 19286462
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo visualization of donepezil binding in the brain of patients with Alzheimer's disease.

  2008influential reference
• Mapping of human cerebral sigma1 receptors using positron emission tomography and [11C]SA4503

  2007cited by this paper
• Evaluation of the binding characteristics of [5-(11)C-methoxy]Donepezil in the rat brain for in vivo visualization of acetylcholinesterase.

  2003influential reference
• Quantitative measurement of cerebral acetylcholinesterase using.

  2001cited by this paper
• Quantitative Measurement of Cerebral Acetylcholinesterase Using [11C]physostigmine and Positron Emission Tomography

  2001cited by this paper
• In vivo quantification of brain serotonin transporters in humans using [11C]McN 5652.

  2000cited by this paper
• Kinetic Analysis of the 5-HT2A Ligand [11C]MDL 100,907

  2000cited by this paper
• Pharmacological evaluation of [11C]donepezil as a tracer for visualization of acetylcholinesterase by PET.

  2000cited by this paper
• Human cerebral acetylcholinesterase activity measured with positron emission tomography: procedure, normal values and effect of age

  1999cited by this paper
• Acetylcholine in mind: a neurotransmitter correlate of consciousness?

  1999cited by this paper
• In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer’s disease

  1999cited by this paper
• The cholinergic hypothesis of Alzheimer’s disease: a review of progress

  1999cited by this paper
• Graphical analysis of PET data applied to reversible and irreversible tracers.

  1999cited by this paper
• A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

  1998cited by this paper
• A JAVA environment for medical image data analysis: initial application for brain PET quantitation.

  1998cited by this paper
• Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease.

  1997cited by this paper
• Performance evaluation of a large axial field-of-view PET scanner: SET-2400W

  1997influential reference
• Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging

  1996cited by this paper
• Positron emission tomography study of [11C]methyl-tetrahydroaminoacridine (methyl-tacrine) in baboon brain.

  1993cited by this paper
• Measurement of Cerebral Monoamine Oxidase B Activity Using L-[11C]Deprenyl and Dynamic Positron Emission Tomography

  1991cited by this paper
• Compartmental Analysis of [11C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission Tomography

  1991cited by this paper
• Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects

  1990influential reference
• Cerebral Blood Volume Measured with Inhaled C15O and Positron Emission Tomography

  1987cited by this paper
• Molecular Forms of Acetylcholinesterase and Butyrylcholinesterase in the Aged Human Central Nervous System

  1986influential reference
• Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.

  1985cited by this paper
• [A biochemical study of cholinergic neurons of the post-mortem brains from the patients with Alzheimer-type dementia].

  1984influential reference
• A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

  1984cited by this paper
• Basal forebrain neurons in the dementia of Parkinson disease

  1983cited by this paper
• Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.

  1982cited by this paper
• Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

  1978cited by this paper
• Selective loss of central cholinergic neurons in Alzheimer's disease.

  1976cited by this paper
• A new look at the statistical model identification

  1974influential reference
• A Simplex Method for Function Minimization

  1965influential reference

• Pharmaceutical Formulations and Analytical Methods of Donepezil

  2025cites this paper
• Positron Emission Tomography Imaging of Synaptic Dysfunction in Parkinson’s Disease

  2024cites this paper
• Gentisic acid exerts neuroprotective effects in neurotoxin-induced Parkinson's disease model in zebrafish: Cross-talk between pathways related with neurodegeneration in the gut-brain axis.

  2024cites this paper
• [11C]Paraoxon: Radiosynthesis, Biodistribution and In Vivo Positron Emission Tomography Imaging in Rat

  2023cites this paper
• Turning the Spotlight to Cholinergic Pharmacotherapy of the Human Language System

  2023cites this paper
• Donepezil alone and combined with intensive language-action therapy on depression and apathy in chronic post-stroke aphasia: A feasibility study.

  2022cites this paper
• Radiotracers for Bone Marrow Infection Imaging

  2021cites this paper
• Pharmacological Treatment of Post-stroke Cognitive Deficits

  2020cites this paper
• Positron emission tomography studies of organophosphate chemical threats and oxime countermeasures.

  2020cites this paper
• The relationship between tumor aggressiveness and cholinergic PET imaging in prostate cancer tissue. A proof-of-concept study.

  2019cites this paper
• PET microdosing of CNS drugs

  2017cites this paper
• Cholinergic Potentiation and Audiovisual Repetition-Imitation Therapy Improve Speech Production and Communication Deficits in a Person with Crossed Aphasia by Inducing Structural Plasticity in White Matter Tracts

  2017cites this paper
• Kinetic Modelling of Infection Tracers [18F]FDG, [68Ga]Ga-Citrate, [11C]Methionine, and [11C]Donepezil in a Porcine Osteomyelitis Model

  2017cites this paper
• Cholinergic PET imaging in infections and inflammation using 11C-donepezil and 18F-FEOBV

  2017influential citation
• Whole-Body Distribution of Donepezil as an Acetylcholinesterase Inhibitor after Oral Administration in Normal Human Subjects: A 11C-donepezil PET Study

  2017cites this paper
• Imaging in Parkinson's disease: time to look below the neck.

  2015cites this paper
• Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET.

  2015cites this paper
• Brain penetration assessment in vivo: a reliable and simple method in anesthetized rats at steady state.

  2014cites this paper
• In Vivo Imaging of Human Acetylcholinesterase Density in Peripheral Organs Using 11C-Donepezil: Dosimetry, Biodistribution, and Kinetic Analyses

  2014influential citation
• PET IMAGING OF THE PHARMACOKINETICS OF SMALL MOLECULAR‐WEIGHT DRUGS

  2013cites this paper
• PET probes for imaging brain acetylcholinesterase.

  2013cites this paper
• Modeling of PET data in CNS drug discovery and development

  2013cites this paper
• DEVELOPMENT OF BUTYRYLCHOLINESTERASE LIGANDS FOR THE IMAGING OF NEUROLOGICAL DISORDERS

  2013cites this paper
• Greater Responsiveness to Donepezil in Alzheimer Patients With Higher Levels of Acetylcholinesterase Based on Attention Task Scores and a Donepezil PET Study

  2012cites this paper
• [5-11C-METHOXY]DONEPEZIL, A PET LIGAND FOR IN-VIVO VISUALIZATION OF DONEPEZIL BINDING TO ACETYLCHOLINESTERASE AND CHOLINERGIC IMAGING

  2012cites this paper
• Cholinergic Deficit and Response to Donepezil Therapy in Parkinson’s Disease with Dementia

  2012cites this paper
• Functional Imaging of the Ageing Brain

  2010cites this paper